Todd Bazemore

Director at Pulmatrix.

Framingham, MA
Pulmatrix

Raised on Pulmatrix filings

$1M

of $1M offered across 1 Form D filing

Form D filings: 1
Teammates: 5
Last filing: Apr 15, 2026

Company

Biotech · Framingham, MA

Inhaled dry powder drugs for migraine and lung disease

Inhaled dry powder drugs for migraine and lung disease

Investors: 1

Investors: 1
Sector: Biotech
HQ: Framingham, MA

Pulmatrix filings

Pulmatrix Form D filings
Filed	Security	Sold of offered	Filing
Apr 15, 2026	Equity	$1M/ $1M	Form D

EquityFiled Apr 15, 2026Form D
$1M/ $1M

Works with

Also named on Pulmatrix filings

Peter LudlumInterim CEO, Interim CFO, Form D signerForm D signer Anand VaradanDirector Christopher CabellDirector Michael HigginsDirector Richard BatyckyDirector